A global healthcare company has agreed to pay $6.3 million to resolve allegations that it violated the False Claims Act by selling items to the United States that were manufactured in non~designated countries in violation of the Trade Agreements Act of 1979, U.S. Attorney Philip R. Sellinger announced today.